The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
Na IK; Lu SX; Yim NL; Goldberg GL; Tsai J; Rao U; Smith OM; King CG; Suh D; Hirschhorn-Cymerman D; Palomba L; Penack O; Holland AM; Jenq RR; Ghosh A; Tran H; Merghoub T; Liu C; Sempowski GD; Ventevogel M; Beauchemin N; van den Brink MR; The Journal Of Clinical Investigation, 2010, vol. 120, issue 1, p 343, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef